Search Press releases Keywords From To 23 Dec 2022 UCB Announces FDA Acceptance of BLA Resubmission for Bimekizumab Read More 19 Dec 2022 FINTEPLA[®]▼ (fenfluramine) oral solution recommended for approval in the EU for adjunctive treatment of seizures associated with Lennox-Gastaut syndrome (LGS) Read More 13 Dec 2022 UCB and Praxis Precision Medicines Announce Epilepsy Research Collaboration Read More 12 Dec 2022 Changes in UCB’s Board of Directors Read More 9 Dec 2022 UCB Announces Positive Phase 3 Studies for Bimekizumab in Hidradenitis Suppurativa Read More 7 Dec 2022 The Lancet Publishes Results from Two Bimekizumab Phase 3 Studies in Psoriatic Arthritis Read More Pagination First page Previous page Previous … Page 30 Page 31 Page 32 Page 33 Current page 34 Page 35 Page 36 Page 37 Page 38 … Page 34 of 60 Next page Next Last page Stay up-to-date on the latest news and information from UCB Subscribe
